HighTower Advisors’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$210K Buy
+3,687
New +$215K ﹤0.01% 3515

Other funds holding PCVX

HighTower Advisors's PCVX Position: Q3 2026 in Review

HighTower Advisors opened a new position in Vaxcyte (PCVX) in Q3 2026: 3,687 shares worth $210K. The stake represents ﹤0.01% of the portfolio and ranks #3515 among its holdings.

283 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.

  • HighTower Advisors held 3,687 shares of Vaxcyte worth $210K as of Q3 2026.
  • Vaxcyte was a new HighTower Advisors position in Q3 2026.
  • Vaxcyte made up ﹤0.01% of HighTower Advisors's portfolio in Q3 2026, its #3515 holding.
  • 283 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.

Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.